Mechanistically, tumor-secreting Gal-1 reprograms the tumor endothelium to upregulate cell-surface programmed death-ligand 1 (PD-L1) and galectin-9, resulting in the inhibition of T cell infiltration [47]. This evidence concerns the gene CD274 and neoplasm.